what company makes retatrutide Tirzepatide vs. Retatrutide: Key Differences Explained Retatrutide Subcutaneous Fat Loss Results:

Fine-needle aspiration biopsy of malignant melanoma: a cytologic and immunocytochemical analysis

This was compared to 5% of patients who received a placebo, a difference that was deemed statistically significant

has received grant support from Merck, Sharp & Dohme

Phase 2 Metabolic Benefits Beyond weight loss, retatrutide improved cardiometabolic markers: Blood pressure: Systolic BP decreased 7.4 mmHg (12mg dose) Triglycerides: Reduced 27% from baseline Fasting glucose: Decreased 13.8 mg/dL HbA1c: Reduced 0.4% (in participants without diabetes) TRIUMPH-4: First Phase 3 Results (December 2025) TRIUMPH-4 was the first Phase 3 trial to report

Improved Skin Texture: Smoother, softer, and more refined skin